Cointime

Catalyst Bioscience

company

About

Catalyst is a biopharmaceutical company focusing on protease therapeutics to address the disorders of coagulation systems.

  • 51 - 100

Highlights

Total Funding Amount
$106M
Funding Rounds
2
Investors
6

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$46M
Industries
Biotechnology,Health Care,Life Science,Medical,Medical Device,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. It is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation. It is focused on protease therapeutics to address unmet medical needs in disorders of the coagulation systems.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$106M
Catalyst Bioscience has raised a total of $106M in funding over 2 rounds. Their latest funding was raised on Mar 20, 2003 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 20, 2003 Series Unknown $60M 2 — — Detail
Dec 5, 2002 Series Unknown $46M 4 Nomura International — Detail

Investors

Number of Lead Investors
Number of Investors
1
6
Catalyst Bioscience is funded by 6 investors. Nomura International and Cogene Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Nomura International Yes Series Unknown
Cogene Ventures — Series Unknown
Jafco Life Science — Series Unknown
Academy Venture Fund — Series Unknown
Genavent — Series Unknown
CDC IXIS Innovation — Series Unknown
Cointime
Content
Company